Sun Pharmaceutical Industries Ltd.
Fundamentals
- Market cap
- ₹4.43 lakh cr
- P/E
- 168.70×
- ROE
- 15.13%
- Debt / equity
- 0.03
- Div yield
- 0.87%
- 52-week range
- 1548.00 — 1916.60
The timeline — 3 notes on Sun Pharmaceutical Industries Ltd.
May 2026
- 22 May 26 · 19:47 IST Brief Brief
Sun Pharma's US innovation revenue overtakes its generics business
Innovative medicine sales hit $1.1B in FY26, but Q4 margins felt the pinch of higher spending and lower milestone income.
- 22 May 26 · 15:04 IST Brief Brief · Earnings
Sun Pharma posts 26% Q4 profit growth and readies tax shift
The drugmaker closed FY26 with a ₹5 final dividend, while preparing to tap a lower tax regime in the new fiscal year.
- 22 May 26 · 14:56 IST Brief Brief · Earnings
Sun Pharmaceutical FY26 growth hits 11.9% as dividends hold steady
A routine year-end filing shows consolidated sales growth and a final ₹5 dividend, maintaining the total payout from the prior year.